Matrices for tissue-engineered skin

被引:25
作者
Hutmacher, DW
Vanscheidt, W
机构
[1] Natl Univ Singapore, Fac Mech Engn, Div Bioengn, Singapore 119260, Singapore
[2] Natl Univ Singapore, Fac Med, Dept Orthopaed Surg, Singapore 119260, Singapore
[3] Clin Wound Biol, Hochenschwand, Germany
关键词
D O I
10.1358/dot.2002.38.2.820107
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Academic, clinical and industrial efforts are increasingly being directed toward the use of molecular- and cell-based therapies for diagnosis and treatment of a great number and broad variety of pathologies and injuries. Hence, tissue engineering is, next to genetic engineering, widely heralded as the healthcare technology heir of the revolutionary advances in life sciences. In a cost-controlled healthcare environment, only those technologies capable of providing a major enhancement to quality of life and a reduction in expenditure will be driven forward. Skin tissue engineering concepts based on the application of a scaffold/cell construct represent a treatment concept with the clear potential to meet this criterion. Several important issues concerning the research and product strategy (e.g., choice of matrix of natural or synthetic polymer origin and the use of autogenic versus allogenic cells) remain to be fully resolved. However, there is little doubt that wound regeneration via modern tissue engineering strategies will present significant therapeutic benefits when compared with existing treatments, This paper reviews the biography and future research directions of matrices used in skin tissue engineering. (C) 2002 Prous Science. All rights reserved.
引用
收藏
页码:113 / 133
页数:21
相关论文
共 109 条
[1]  
ACHAUER BM, 2001, CULTURED HUMAN KERAT, P37
[2]   A new model of epidermal culture for the surgical treatment of vitiligo [J].
Andreassi, L ;
Pianigiani, E ;
Andreassi, A ;
Taddeucci, P ;
Biagioli, M .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 1998, 37 (08) :595-598
[3]  
ANG TH, IN PRESS FABRICATION
[4]  
[Anonymous], PRINCIPLE TISSUE ENG
[5]  
AUGUSTIN M, 2001, DERMATOL PSYCHOSOM, V2, P34
[6]  
Bakos D, 2000, Polim Med, V30, P57
[7]  
BARONIO G, 1804, INNESTI ANIMALI MILA
[8]   CELL-SIZE AS A DETERMINANT OF THE CLONE-FORMING ABILITY OF HUMAN KERATINOCYTES [J].
BARRANDON, Y ;
GREEN, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (16) :5390-5394
[9]   LIVING TISSUE FORMED INVITRO AND ACCEPTED AS SKIN-EQUIVALENT TISSUE OF FULL THICKNESS [J].
BELL, E ;
EHRLICH, HP ;
BUTTLE, DJ ;
NAKATSUJI, T .
SCIENCE, 1981, 211 (4486) :1052-1054
[10]   DEVELOPMENT AND USE OF A LIVING SKIN EQUIVALENT [J].
BELL, E ;
EHRLICH, HP ;
SHER, S ;
MERRILL, C ;
SARBER, R ;
HULL, B ;
NAKATSUJI, T ;
CHURCH, D ;
BUTTLE, DJ .
PLASTIC AND RECONSTRUCTIVE SURGERY, 1981, 67 (03) :386-392